The CDC's Advisory Committee on Immunization Practices (ACIP) has voted by 8 to 3 to remove the recommendation that all ...
At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy ...
The EMBOLD study of relutrigine (also known as PRAX-562) was testing the oral drug in patients with SCN2A and SCN8A ...
Protego Biopharma is poised to start pivotal trials of its amyloid light-chain (AL) amyloidosis drug candidate, thanks to a ...
A CDMO plays a crucial role in the pharmaceutical and biotechnology industries by providing comprehensive drug development ...
CD19-targeted therapy Breyanzi (lisocabtagene maraleucel) can now be used to treat adults with MZL – a rare and form of ...
The verdict is the latest twist in patent litigation between MSD and Halozyme, in which the latter is claiming that Keytruda ...
Despite their readiness, blood centres remain an underutilised lever in pharma’s innovation model. As industry players seek ...
Seven digital health technologies (DHTs) that can be used to support people recovering from cardiovascular diseases have been ...
A new care pathway has emerged in the United States, and patients are already using it every day. Direct-to-patient (DTP) platforms – defined as a digitally enabled, end-to-end treatment model in ...
Sanofi has called time on breast cancer candidate amcenestrant – at one time one of its top pipeline prospects – after it missed the mark in another clinical trial. The decision to abandon development ...
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results